The Enterprise Value as of November 2024 (TTM) for ZIVO Bioscience, Inc. (ZIVO) is 73.95M

According to ZIVO Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 73.95M. This represents a change of 187.04% compared to the average of 25.76M of the last 4 quarters.

ZIVO Bioscience, Inc. (ZIVO) Historical Enterprise Value (quarterly & annually)

How has ZIVO Enterprise Value performed in the past?

The mean historical Enterprise Value of ZIVO Bioscience, Inc. over the last ten years is 10.51M. The current 73.95M Enterprise Value has changed 70.29% with respect to the historical average. Over the past ten years (40 quarters), ZIVO's Enterprise Value was at its highest in in the September 2024 quarter at 55.93M. The Enterprise Value was at its lowest in in the December 2023 quarter at 2.16M.

ZIVO Bioscience, Inc. (ZIVO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ZIVO Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ZIVO Bioscience, Inc. (ZIVO) Average Enterprise Value

How has ZIVO Enterprise Value performed in the past?

The current Enterprise Value of ZIVO Bioscience, Inc. (ZIVO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ZIVO Bioscience, Inc. (ZIVO) Enterprise Value vs. Peers

How is ZIVO’s Enterprise Value compared to its peers?

ZIVO Bioscience, Inc.’s Enterprise Value is greater than RenovoRx, Inc. (21.40M), greater than Pasithea Therapeutics Corp. (-5435245.00), greater than Quoin Pharmaceuticals, Ltd. (-162664.00), greater than ARCA biopharma, Inc. (1.56M), less than Theseus Pharmaceuticals, Inc. (0), less than Erasca, Inc. (138.26M), less than Forte Biosciences, Inc. (747.42M), greater than Applied Molecular Transport Inc. (7.03M), greater than Senti Biosciences, Inc. (-5743713.00), greater than Cadrenal Therapeutics, Inc. Common Stock (34.09M), greater than Foghorn Therapeutics Inc. (20.50M), less than Tempest Therapeutics, Inc. (417.24M), greater than Ikena Oncology, Inc. (35.14M), greater than Catalyst Biosciences, Inc. (45.73M), greater than null (19.42M),

Build a custom stock screener for ZIVO Bioscience, Inc. (ZIVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZIVO Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ZIVO Bioscience, Inc. (ZIVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ZIVO Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.